Corteva Financial Model
Chemicals Company Financials Example (Free Excel Download)
Corteva, Inc. (CTVA) is a global pure-play agriculture company that provides farmers with a comprehensive portfolio of seed, crop protection, and digital solutions.
professionals from Deloitte
Used by professionals from
About this model
This model provides a comprehensive equity valuation and scenario planning tool for an analyst evaluating Corteva's core earnings power, seasonal working capital dynamics, and the financial impact of its planned 2026 business separation.
Corteva, Inc. (CTVA) is a global pure-play agriculture company that provides farmers with a comprehensive portfolio of seed, crop protection, and digital solutions. Spun off from DowDuPont in 2019, the company focuses on maximising agricultural productivity and sustainability through advanced genetics, biologicals, and synthetic chemistry.
- Business segments: Seed (approximately 57% of revenue) and Crop Protection (approximately 43% of revenue).
- Key geographies: North America (largest market), Latin America (driven by Brazil), EMEA, and Asia Pacific.
- Business model type: Asset-heavy manufacturing combined with high-margin intellectual property licensing and R&D-driven product development.
- Competitive position: A top-tier global agriscience player, holding significant market share in corn and soybean seeds alongside Bayer and Syngenta, with a growing presence in the biologicals market.
- Recent major events: The company completed acquisitions in the biologicals space (Symborg and Stoller in 2023), initiated a major Crop Protection restructuring programme to optimise its manufacturing network (expected to complete in 2026), and announced a planned separation into two independent companies targeted for the second half of 2026.
The downloadable Corteva financial model includes SEC-sourced historical financials, forecast assumptions, core operating schedules, and valuation outputs in an Excel workbook built for review and scenario analysis.
A turnkey financial model
Live formulas, no hardcoded values
Outputs are driven by live formulas, so the workbook updates from its assumptions instead of relying on hardcoded results.
All assumptions in one tab
Inputs are clearly marked in the Assumptions tab and separated from calculations, making it clear what to change and what to leave intact.
Statements always balancing
For integrated-statement models, the balance sheet, cash flow, and supporting schedules tie through properly.
Distinct schedules for clarity
Debt, working capital, taxes, and cash flow can get messy quickly. We group calculations in clear schedules, not across disconnected tabs.
No hidden macros or external links
There are no unexplained external workbook links or macros to undermine auditability or portability.
Changes flow through the model
Update a key driver and see the impact carry through the forecast, financing, and return outputs. We never use hardcoded numbers in formulas.
Historicals & AssumptionsCorteva financial modelCompany, Historicals & Assumptions used
Source: SEC EDGAR · values in USD
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $15.65B | $17.45B | $17.23B | $16.91B | $17.40B |
| Gross profit | $6.43B | $7.02B | $7.31B | $7.38B | $8.23B |
| Cost of goods sold | $9.22B | $10.44B | $9.92B | $9.53B | $9.17B |
| Net income | $1.76B | $1.15B | $735.0M | $907.0M | $1.09B |
Forecast assumptions
Defaults used in the downloadable model. Forecast horizon: FY2026–FY2030.
See 8 moreSee less
How to build a detailed financial model for Corteva
A complete walkthrough of every driver, margin, working-capital input, and capital-allocation assumption used in the downloadable model.
Revenue Deep Dive
Seed
- Segment name: Seed
- Revenue driver formula: Planted Acres x Market Share x Price/Mix (driven by trait technology adoption)
- Historical growth rate: 1% to 4% CAGR over the last 3 years.
- Key growth levers and headwinds: Growth is driven by the adoption of premium trait technologies (such as Enlist E3) and market share gains in North America and Brazil. Headwinds include shifts in planted area (e.g., farmers switching from corn to soybeans) and adverse weather conditions delaying planting seasons.
- Pricing dynamics: Highly value-driven. Corteva employs a "price for value" strategy, capturing the yield benefits its genetics provide to farmers. Pricing is largely contractual but influenced by global commodity crop prices.
- Revenue recognition notes: Revenue is recognised when control transfers to the customer, typically upon delivery. However, significant out-licensing income is recognised based on contractual milestones or usage.
- Seasonality: Highly seasonal. The first and fourth quarters are typically strongest for North America, while the third and fourth quarters capture the Latin American "safrinha" (second crop) season.
Crop Protection
- Segment name: Crop Protection
- Revenue driver formula: Volume (Litres/Kilograms sold) x Price per Unit
- Historical growth rate: Volatile, ranging from negative 2% to positive 5% depending on channel destocking and currency impacts.
- Key growth levers and headwinds: Growth is fuelled by new product launches (e.g., Reklemel, Rinskor) and the rapidly expanding biologicals portfolio. Headwinds include generic pricing pressure, particularly in Latin America, and global channel destocking.
- Pricing dynamics: Highly competitive and sensitive to generic alternatives. Pricing power is maintained through patented, differentiated formulations.
- Revenue recognition notes: Recognised upon delivery to distributors or direct customers. Rebates and sales incentives are estimated and recorded as a reduction to revenue at the time of sale.
- Seasonality: Follows the global application seasons, with strong demand in the Northern Hemisphere spring (Q1/Q2) and Southern Hemisphere spring (Q3/Q4).
Cost Structure
Variable Costs / COGS
- COGS primarily consists of raw materials (petrochemical derivatives for Crop Protection), seed production costs (grower compensation, conditioning, packaging), and royalty expenses paid to third parties for trait technologies.
- Gross margin typically ranges between 40% and 45%.
- Key input costs include energy, logistics, and agricultural commodities.
- COGS scales linearly with volume, but the company is actively reducing third-party royalty expenses (aiming to be royalty-neutral by 2026), which provides structural gross margin expansion.
Operating Expenses
- R&D: Typically runs at 6% to 8% of revenue. It covers traditional chemistry discovery, plant breeding, and advanced gene editing technologies. Most R&D is expensed as incurred.
- SG&A: Includes a massive global sales force and agronomic support network. It is largely headcount-driven and represents approximately 15% to 18% of revenue.
- Depreciation & Amortisation: Averages 3% to 4% of revenue, heavily weighted towards the amortisation of intangible assets acquired during the DowDuPont merger.
- Stock-Based Compensation: Runs at approximately 0.5% to 1.0% of revenue.
- Restructuring / one-time charges: Frequent in recent years. The company expects $160 million to $175 million in pre-tax restructuring charges in 2025 related to Crop Protection network optimisation.
Margin Profile
- Gross margin: 40% to 45%.
- Operating EBITDA margin: Has expanded from the mid-teens to approximately 22.1% in 2025.
- Net margin: 5% to 8%, heavily impacted by amortisation and restructuring charges.
- Segment margins: Seed typically commands higher operating EBITDA margins (mid-20s) compared to Crop Protection (mid-to-high teens).
Balance Sheet Structure
- Total assets are in the range of $40 billion to $45 billion.
- Key asset categories include massive inventory balances (due to the long seed production cycle) and significant intangible assets.
- Goodwill and intangibles represent over 40% of total assets, a legacy of the Dow and DuPont merger and subsequent spin-off.
- Working capital profile:
- Days Sales Outstanding (DSO): 90 to 100 days (extended terms are common in agriculture).
- Days Inventory Outstanding (DIO): 220 to 230 days (seed must be grown a year in advance).
- Days Payable Outstanding (DPO): 160 to 170 days.
- Net working capital is highly positive and represents a significant use of cash during the first half of the year, reversing in the second half.
- PP&E consists of global manufacturing facilities for chemicals and seed conditioning plants.
- Right-of-use assets are material but manageable, representing standard corporate and logistics leases.
Capital Expenditure & Investment
- Capex as a percentage of revenue consistently runs between 3.0% and 4.0% (approximately $590 million in 2025).
- The split is roughly 60% maintenance and 40% growth, with growth capex directed towards biologicals manufacturing and seed conditioning automation.
- Capitalised software is a minor component compared to physical plant investments.
- M&A pattern: Historically a bolt-on acquirer focusing on biologicals (e.g., Symborg, Stoller) to fill portfolio gaps rather than transformational M&A.
Debt & Capital Structure
- Total debt is approximately $2.5 billion to $3.0 billion, with net debt often near zero or slightly positive due to strong cash balances.
- Debt/EBITDA ratio is very conservative, typically running below 1.0x.
- Credit rating is investment grade.
- Key debt instruments include senior unsecured notes and a commercial paper programme supported by a revolving credit facility.
- The maturity profile is well-laddered with no immediate liquidity cliffs.
- Interest rate profile is predominantly fixed via long-term bonds.
- The share repurchase programme is highly active, with management targeting approximately $1.0 billion in buybacks for 2025.
- Dividend policy is progressive, with a yield of approximately 1.5% and regular annual increases.
Cash Flow Characteristics
- Operating cash flow conversion is strong, with OCF frequently exceeding Net Income due to heavy non-cash amortisation charges.
- Free cash flow margin typically ranges from 10% to 15% of revenue ($1.7 billion to $2.9 billion in recent years).
- Major non-cash items include depreciation, amortisation of DowDuPont intangibles, and stock-based compensation.
- Working capital is a massive seasonal driver; the company builds inventory and receivables in Q1/Q2 and collects cash in Q3/Q4.
- Capex intensity is relatively low for a chemical manufacturer, supporting high free cash flow generation.
Sheet Structure
- Assumptions: Hardcoded drivers for macroeconomic factors, segment growth, margins, and capital allocation.
- Scenarios: Toggle for base case, downside (commodity price crash), and upside (rapid biologicals adoption).
- Income Statement: Consolidated view mirroring the 10-K, down to Net Income and EPS.
- Segment Build: Detailed revenue and Operating EBITDA build for Seed and Crop Protection, including volume and price/mix drivers.
- Balance Sheet: Standard assets, liabilities, and equity, with detailed working capital lines (Trade Receivables, Inventories, Trade Payables).
- Cash Flow Statement: Indirect method starting from Net Income, detailing working capital changes, capex, and financing activities.
- Working Capital Schedule: Monthly or quarterly build of DSO, DIO, and DPO to capture extreme agricultural seasonality.
- Debt & Interest Schedule: Tranche-by-tranche debt build, interest expense calculation, and commercial paper tracking.
- PPE & Intangibles Schedule: Capex, depreciation, and amortisation waterfall.
- Tax Schedule: Book-to-tax bridge and effective tax rate calculation.
- Equity & Shares Schedule: Retained earnings roll-forward, share repurchases, and basic/diluted share count.
- DCF Valuation: Unlevered free cash flow build, WACC calculation, and terminal value.
- Outputs & Charts: Summary dashboard for the analyst.
Key Financial Relationships
- Seed Revenue = Prior Year Seed Revenue x (1 + Seed Volume Growth) x (1 + Seed Price/Mix Growth) x (1 + FX Impact)
- Crop Protection Revenue = Prior Year CP Revenue x (1 + CP Volume Growth) x (1 + CP Price Growth) x (1 + FX Impact)
- Consolidated Net Sales = Seed Revenue + Crop Protection Revenue
- Seed Operating EBITDA = Seed Revenue x Seed Operating EBITDA Margin
- Crop Protection Operating EBITDA = Crop Protection Revenue x Crop Protection Operating EBITDA Margin
- Total Operating EBITDA = Seed Operating EBITDA + Crop Protection Operating EBITDA - Corporate Expenses
- Trade Receivables = (Consolidated Net Sales / 365) x DSO
- Inventories = (COGS / 365) x DIO
- Trade Payables = (COGS / 365) x DPO
- Free Cash Flow = Cash Provided by Operating Activities - Capital Expenditures
- Interest Expense = Average Debt Balance x Weighted Average Interest Rate
- Diluted Shares Outstanding = Prior Period Shares - (Share Repurchases / Average Share Price) + Stock-Based Comp Issuances
Cross-Sheet Dependencies
- The Segment Build sheet feeds directly into the top line of the Income Statement.
- The Income Statement generates Net Income, which is the starting point for the Cash Flow Statement.
- The Working Capital Schedule uses revenue and COGS from the Income Statement to calculate balance sheet accounts, and the period-over-period changes feed the Cash Flow Statement.
- The PPE & Intangibles Schedule calculates depreciation and amortisation, feeding both the Income Statement (operating expenses) and the Cash Flow Statement (non-cash add-backs).
- The Debt & Interest Schedule uses cash flow deficits/surpluses from the Cash Flow Statement to determine revolver drawdowns, and feeds interest expense back to the Income Statement. This is a potential circularity loop that must be managed with a toggle.
Sign Convention
- Revenue, assets, and equity are represented as positive numbers.
- Expenses (COGS, SG&A, R&D, Interest) are represented as positive numbers in their specific schedules but subtracted in summation formulas (e.g., Gross Profit = Revenue - COGS).
- On the Cash Flow Statement, cash inflows are positive and cash outflows (including Capex, dividends, and share repurchases) are negative.
- Contra-asset accounts (like accumulated depreciation) are represented as negative numbers.
Things Most Likely to Go Wrong
- Extreme Seasonality: The agricultural cycle means Q1 and Q4 hold the bulk of North American sales, while Q3/Q4 hold Latin American sales. Weather delays can easily push hundreds of millions in revenue across quarter boundaries, breaking quarterly models.
- FX Translation: Corteva has massive exposure to the Brazilian Real and Turkish Lira. A model that ignores constant-currency adjustments will misinterpret underlying organic growth.
- Royalty Expense Dynamics: The company is actively replacing third-party traits with proprietary traits (Enlist E3). Models must account for COGS margin expansion as royalty expenses decline towards zero by 2026.
- Restructuring Noise: GAAP earnings are heavily distorted by ongoing Crop Protection network optimisation charges. The model must clearly separate GAAP Net Income from Operating EBITDA.
- Intangible Amortisation: The legacy DowDuPont merger created massive intangible assets. Excluding this non-cash amortisation from adjusted earnings is critical for true cash flow analysis.
- Working Capital Swings: Free cash flow is often negative in Q1 due to inventory builds. Annualising Q1 cash flow will result in catastrophic valuation errors.
- Separation Pro-Forma: The planned 2026 separation will introduce dis-synergies (estimated at $50 million). The model must account for these stranded costs in the outer years.
- Biologicals Growth: Crop Protection volume growth is increasingly driven by biologicals, which have a different margin profile than traditional synthetic chemistry.
Validation Checks
- "Consolidated Operating EBITDA margin should be in the 21% to 23% range; flag if outside this band."
- "Capex as a percentage of revenue should remain between 3.0% and 4.0% based on historical averages."
- "Free Cash Flow to Operating Cash Flow conversion should exceed 70%."
- "Days Inventory Outstanding (DIO) must remain above 200 days due to the biological reality of seed production."
- "Total Assets must exactly equal Total Liabilities plus Equity in every modelled period."
- "Debt/EBITDA should remain below 1.5x, reflecting the company's conservative balance sheet."
- "Effective tax rate should hover between 20% and 22%."
- "Annual share repurchases should not exceed Free Cash Flow minus Dividends without triggering a debt drawdown flag."
Key Assumptions (Default Values)
| Assumption | Default Value | Unit | Rationale |
|---|---|---|---|
| Seed Revenue Growth | 4.0 | % | Based on FY2025 actual growth driven by price/mix and market share gains |
| Crop Protection Revenue Growth | 2.0 | % | Based on FY2025 actuals and management's 2026 guidance |
| Seed Operating EBITDA Margin | 26.6 | % | Derived from FY2025 segment EBITDA performance |
| Crop Protection Operating EBITDA Margin | 16.5 | % | Derived from FY2025 segment EBITDA performance |
| Consolidated Operating EBITDA Margin | 22.1 | % | FY2025 actual reported margin |
| Capex as % of Revenue | 3.5 | % | 5-year historical average |
| Days Sales Outstanding (DSO) | 97 | Days | Historical average reflecting agricultural credit terms |
| Days Inventory Outstanding (DIO) | 229 | Days | Historical average reflecting long seed production cycles |
| Days Payable Outstanding (DPO) | 162 | Days | Historical average |
| Effective Tax Rate | 21.0 | % | Estimated based on historical GAAP tax rates and global mix |
| Share Repurchases | 1,000 | USD m | Management guidance for 2025/2026 capital return programme |
| Dividend Yield | 1.5 | % | Current run-rate based on recent declarations |
| WACC | 8.5 | % | Standard discount rate for large-cap agriscience companies |
| Terminal Growth Rate | 2.0 | % | Long-term inflation and global agricultural demand alignment |
Data Sources & Benchmarks
- SEC Filings: Corteva's 10-K and 10-Q filings can be found on the SEC EDGAR database or the Corteva Investor Relations website.
- Key Peers for Benchmarking: Bayer AG (BAYN.DE), Syngenta Group (private/ChemChina), FMC Corporation (FMC), and Nutrien Ltd (NTR).
- Industry Data Sources: USDA WASDE (World Agricultural Supply and Demand Estimates) reports for planted acreage and crop prices; FAO data for global agricultural trends.
- Consensus Estimates: Bloomberg or FactSet for forward-looking analyst estimates on revenue and EBITDA.
- Proprietary Data: AgbioInvestor for crop protection market share data; Kynetec for seed trait adoption rates.
Sources
- Corteva Q4 2025 Earnings Release and Presentation (February 2026)
- Corteva 2024 Annual Report on Form 10-K
- Corteva Q3 2025 Earnings Conference Call Transcripts
- Corteva Investor Relations Website (investors.corteva.com)
- SEC EDGAR Database (sec.gov)
- ValueInvesting.io DCF Valuation Metrics for CTVA
- Finbox Capital Expenditure Historical Data for CTVA
Do more with the Corteva model
Frequently asked
What is Corteva's primary business focus and what solutions does it offer?+
Corteva, Inc. (CTVA) is a global pure-play agriculture company dedicated to providing farmers with a comprehensive portfolio of seed, crop protection, and digital solutions. The company focuses on maximizing agricultural productivity and sustainability through advanced genetics, biologicals, and synthetic chemistry.
What are Corteva's main revenue segments and key geographical markets?+
Corteva's revenue is primarily generated from its Seed segment, which accounts for approximately 57% of total revenue, and its Crop Protection segment, contributing about 43%. Its key geographical markets include North America, Latin America (driven by Brazil), EMEA, and Asia Pacific.
What is the assumed revenue growth rate for Corteva in the financial model?+
The financial model for Corteva assumes a revenue growth rate of approximately 5.6% for the forecast horizon from FY2026 to FY2030. This growth reflects the company's focus on its core agricultural solutions and strategic initiatives.
How does Corteva's working capital profile affect its cash flow dynamics?+
Corteva's net working capital is highly positive and represents a significant use of cash during the first half of the year, which then reverses in the second half. This dynamic is largely due to the massive inventory balances required for its long seed production cycle and the extended payment terms common in the agriculture industry.
What is a key assumption for Corteva's capital expenditure in the financial model?+
In the financial model, Corteva's capital expenditure (Capex) is assumed to be approximately 4.5% of revenue. This includes roughly 60% for maintenance and 40% for growth initiatives, such as biologicals manufacturing and seed conditioning automation.
What is the purpose of the downloadable Excel financial model for Corteva?+
The downloadable Excel model for Corteva serves as a comprehensive equity valuation and scenario planning tool for analysts. It helps in evaluating the company's core earnings power, understanding its seasonal working capital dynamics, and assessing the financial impact of its planned 2026 business separation.
Have more financial modelling questions? Contact us
Created by ex-finance professionals
Hey, I’m Alex and I created Finamodel.
Over my years in the finance industry I kept building the same models over and over again. Same structure, same assumptions, different logo. So I started building frameworks to turn them into clean, reusable templates.
Every model here is one I’d actually use for a client, and I personally vet each one before it goes up.
I’m not an expert in every industry, but I’ve built enough models to know what belongs in one. And when something is completely foreign to me, I reach out to my network for experts to work on our models with us.
Having a template library on hand cuts a first build from hours to minutes.
Need help finding your model? You’ll find me in the Finamodel app!
Other Chemicals Company Financial Models
Browse another company in the same sector.
Albemarle
Albemarle Corporation is a global specialty chemicals company and one of the world's largest producers of lithium and bromine.
Air Products
Air Products and Chemicals, Inc.
CF Industries
CF Industries Holdings, Inc.
DuPont
DuPont is a global advanced materials and engineered solutions company that provides highly specified products to regulated and performance-critical industries, including medical packaging, water filtration, and engineered materials for aerospace and construction.
Dow
Dow is a global materials science company that produces plastics, chemicals, and agricultural products for packaging, infrastructure, mobility, and consumer applications, operating integrated manufacturing sites that convert hydrocarbon feedstocks into value-added chemical products.
Ecolab
Ecolab is a global leader in water, hygiene, and infection prevention solutions and services, providing proprietary chemicals and dispensing equipment to industrial, hospitality, healthcare, and life sciences customers via a direct field sales and service force.
International Flavors & Fragrances
International Flavors & Fragrances (IFF) is a global leader in the creation of value-added ingredients for the food, beverage, health, biosciences, and scent markets.
Linde
Linde plc is the world's largest industrial gas and engineering company, producing atmospheric and process gases for a variety of end markets including chemicals, manufacturing, healthcare, and electronics.
Explore more Manufacturing financial model templates.
